Stay updated on Adagrasib with Palbociclib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Adagrasib with Palbociclib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Adagrasib with Palbociclib in Advanced Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from 2025-03-25 to 2025-02-11.SummaryDifference1.0%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check80 days agoChange DetectedThe page has been updated to reflect a new completion status and a future date of February 11, 2025, while removing the previous status of being active but not recruiting and a date of August 5, 2024.SummaryDifference2%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference6%
Stay in the know with updates to Adagrasib with Palbociclib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib with Palbociclib in Advanced Solid Tumors Clinical Trial page.